The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs provide critical funding for small businesses to advance innovative research and development (R&D). However, strict oversight under Federal Acquisition Regulation (FAR) Part 31, 2 CFR Part 200, and Defense Contract Audit Agency (DCAA) standards mandates that awardees adhere to precise guidelines on allowable costs. A key prohibition is the use of SBIR/STTR funds to pay contingent fees to grant writers, fees dependent on securing a grant. Therefore, contingent fees are expressly unallowable. Suppose a grant writer advises using SBIR/STTR funds for such costs, and a grant accounting firm fails to challenge this. In that case, the business remains ultimately responsible for compliance and any misuse of funds. This article examines the liability risks, potential recourse against service providers, and strategies to ensure compliance, drawing on federal examples for successful SBIR compliance. [7]

The Liability of Paying Contingent Fees

Contingent fees, which may be a set amount or typically 10–15% of the grant amount, paid only upon award success, are prohibited under FAR 31.205-33(f), which bans such fees for securing government contracts or grants ^[1][5].

“(b)Costs of professional and consultant services are allowable subject to this paragraph and paragraphs (c) through (f) of this subsection when reasonable concerning the services rendered and when not contingent upon recovery of the costs from the Government… “

Note that this prohibition applies to all government agencies and applies to both direct costs (e.g., project-specific expenses) and indirect costs (e.g., facilities and administrative (F&A) costs), as they do not align with the SBIR/STTR programs’ focus on R&D and commercialization ^[1]. Also, important to note is that FAR 31 and all its clauses govern all commercial contracts with for-profit entities.

In addition to the FAR prohibition, agency-specific guidance, such as the NIH Grants Policy Statement and SBA guidelines, emphasizes that funds must support project objectives, not success-based commissions ^[1]. If a grant writer advises paying their contingent fees with SBIR/STTR funds and an accounting firm fails to flag this as unallowable, the business, not the service providers, bears full liability for any resulting non-compliance and misuse of funds.

DCAA and Other Audits

An audit, such as DCAA’s Incurred Cost Audit or NSF’s Cost Analysis and Pre-Award (CAP) review, will hold the business accountable for:

1. Repayment Requirement: Misusing funds for contingent fees is subject to repayment. For example, paying a $30,000 contingent fee from a $314,363 Phase I award could necessitate refunding that amount, straining cash flow and potentially halting R&D, as seen in cases where firms faced disallowed costs ^[7].
2. Audit and Compliance Issues: Non-compliance triggers audits per DCAA’s SF1408 or CAP reviews, which scrutinize costs against FAR 31.205 and 2 CFR § 200.403. Unallowable fees can flag an inadequate accounting system, risking award termination or future funding bans, with violations reported to SAM.gov ^[1][7].
3. Penalties and Sanctions: Violations may incur fines under the False Claims Act (31 U.S.C. § 3729), up to three times the misused amount plus $13,946–$27,894 per violation (as of 2025). Criminal fraud charges are possible if misrepresentations are made intentionally, which can have a severe impact on small businesses ^[2][7].
4. Reputational Risk: Non-compliance damages credibility with key stakeholders, including agencies, investors, and partners.

The business’s responsibility cannot be shifted to grant writers or accountants, as federal regulations hold the awardee accountable for ensuring funds are used appropriately ^[7].

Recourse Against Grant Writers and Accounting Firms

While the business bears primary liability, there are limited avenues for recourse against grant writers or accounting firms whose advice or inaction contributes to non-compliance. These options, however, are challenging and do not absolve the business of government penalties ^[7].

Contractual Remedies:

• Indemnification Clauses: If contracts with grant writers or accounting firms include indemnification clauses, the business may seek compensation for losses caused by negligent advice (e.g., recommending contingent fees). Proving negligence requires clear documentation, such as emails explicitly advising unallowable payments, and is difficult unless misconduct is evident ^[7]. For example, a firm might recover costs if a grant writer’s contract guaranteed compliance but advised a 10% contingent fee, leading to an audit.
• Limitations: Indemnification does not relieve the business of repaying misused funds to the government. Success depends on proving direct causation, which courts rarely accept, given the business’s ultimate responsibility ^[7].

Professional Liability:

Grant writers and accountants are expected to adhere to federal regulations (e.g., FAR 31.205-33) and professional standards, such as those established by the Grant Professionals Association (GPA) or the American Institute of Certified Public Accountants (AICPA). Advising contingent fees or failing to flag them as unallowable may constitute malpractice. However, pursuing a professional liability claim is complex, as courts uphold the business’s duty to verify compliance ^[2][7].

For instance, a business might claim an accounting firm neglected to warn about FAR 31.205-33(f), but proving this caused the misuse is challenging, especially if the business approved the payment.

Ethical and Professional Standards:

Grant writers who advise on contingent fees violate the GPA and American Evaluation Association (AEA) ethics, which prohibit success-based compensation due to conflict-of-interest risks ^[2]. Businesses can report such misconduct to these organizations, which may lead to disciplinary actions, such as membership revocation. However, this does not recover financial losses or mitigate government penalties ^[2][6].

Similarly, accounting firms that fail to ensure compliance may face AICPA complaints, but the outcomes are limited to professional sanctions, not financial recourse ^[7].

Legal Action:

In cases of apparent negligence or fraud (e.g., a grant writer knowingly advising unallowable fees to inflate costs), businesses may pursue lawsuits for damages. However, legal action is costly, time-consuming, and uncertain, as courts often prioritize the business’s responsibility to ensure compliance ^[7]. The government will still require repayment of misused funds, regardless of private lawsuits.

Summary Table

Recourse Option	Description	Likelihood of Success/Impact
Indemnification Clause	Seek compensation if contract allows and negligence is proven	Possible, but requires strong evidence; does not absolve government liability
Professional Liability	Claim against the grant writer or the accountant for malpractice	Challenging, the business retains ultimate responsibility
Professional Complaint	Report to GPA, AEA, or AICPA for ethical violations	May result in disciplinary action; no financial recovery
Legal Action	Lawsuit for damages if negligence or fraud is clear	Complex, costly, and uncertain; government penalties persist

Strategies to Mitigate Risks and Ensure Compliance

To avoid the risks of contingent fees and ensure compliance, SBIR/STTR awardees should adopt these strategies, informed by federal guidelines and best practices:

1. Use DCAA-compliant accounting systems: Implement tools like QuickBooks with a free timekeeping system (E.g., Clockify) to track costs in real-time, ensuring compliance with FAR and agency rules. These systems support cost segregation, including direct (e.g., research labor) and indirect (e.g., utilities) costs, as well as allowable and unallowable expenses. As a result, they can exclude prohibited costs from government funding cost structures and submissions. ^[3][6].
2. Train Staff on Cost Allowability: Educate teams on FAR 31.205, NIH’s Grants Policy Statement, and agency-specific limits (e.g., NSF’s 150% indirect and fringe cap). Training significantly reduces errors and is a best practice in the industry ^[1][3].
3. Engage Fixed-Rate Consultants: Hire grant writers on a fixed-rate basis (e.g., hourly rates), which is allowable as an indirect cost under FAR 31.205-33 if it is reasonable and necessary. When hiring a grant writer or other consultants, use fixed-rate fee agreements to ensure compliance with relevant regulations. ^[3][7]
4. Leverage FAST and TABA Programs: Use Federal and State Technology (FAST) grants or TABA funds for compliant support, such as patent preparation. DOE’s Phase 0 Program, launched in 2014, provided free proposal assistance, boosting application success without contingent fees ^[6].
5. Maintain robust audit trails by storing records in secure cloud systems, such as AWS, QuickBooks, and Box.com, for the required period, as per 2 CFR § 200.334, and linking transactions to supporting evidence (e.g., invoices) ^[3][6].
6. Vet Grant Writers and Accountants: Select professionals familiar with SBIR/STTR regulations and GPA/AEA ethics. Avoid those offering contingent fees, as advised in Reddit discussions, which highlight ethical concerns ^[2][3].

Integration with SBIR/STTR Financial Management

Paying contingent fees disrupts SBIR/STTR financial management by introducing unallowable costs, risking audit failures, and potentially leading to funding loss. Compliant alternatives like fixed-rate fees or TABA funds align with NIH’s budget guidelines and support accurate Financial Status Reports (FSRs) and Incurred Cost Proposals (ICPs) ^[2][7]. Immediate expense visibility, as emphasized in industry best practices, prevents misallocation and supports audit readiness per DCAA’s SF1408 ^[5][6]. For projects like the Army’s PORTAL or Noria’s desalination effort, avoiding contingent fees maintains compliance and stakeholder trust, facilitating Phase III commercialization ^[3][6].

Conclusion

If a grant writer advises using SBIR/STTR funds for contingent fees and an accounting firm fails to challenge this, the business remains liable for compliance and any misuse of funds. Audits will hold the company accountable for repayments, fines, and penalties. The company will have limited recourse against service providers due to the high burden of proving negligence. By adopting fixed-rate contracts, leveraging FAST/TABA programs, and maintaining robust accounting systems, businesses can ensure compliance and minimize risks.

References

1. SBIR Tutorial 4: Cost Acceptability: https://www.sbir.gov/tutorials/accounting-finance/tutorial-4
2. NIH SEED: Understanding SBIR/STTR: https://seed.nih.gov/small-business-funding/small-business-program-basics/understanding-sbir-sttr
3. SBIR Basics: Costs of SBIR/STTR Funding: https://sbirbasics.com/2025/04/costs-sbir-and-sttr-funding/
4. SBIR Tutorial 6: Negotiating an SBIR/STTR Phase II Budget: https://www.sbir.gov/tutorials/accounting-finance/tutorial-6
5. SBIR Basics: Contingent Fees and SBIR/STTR Grant Funds: https://sbirbasics.com/2025/04/contingent-fees-and-sbir-sttr-grant-funds-a-word-of-caution/
6. SBIR Tutorial 7: Incurred Cost Proposals and Audits: https://www.sbir.gov/tutorials/accounting-finance/tutorial-7
7. NIH Grants Policy Statement: Allowable Costs and Fee: https://grants.nih.gov/grants/policy/nihgps/html5/section_18/18.5.4_allowable_costs_and_fee.htm
8. FAR Subpart 3.4: Contingent Fees: https://www.acquisition.gov/far/subpart-3.4

1e50343b0933b9eff8dde0d57549ed56